Robert A. Lipper

595 total citations
8 papers, 323 citations indexed

About

Robert A. Lipper is a scholar working on Molecular Biology, Pharmaceutical Science and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert A. Lipper has authored 8 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pharmaceutical Science and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert A. Lipper's work include Drug Solubulity and Delivery Systems (3 papers), Biochemical and Molecular Research (2 papers) and Pharmaceutical studies and practices (2 papers). Robert A. Lipper is often cited by papers focused on Drug Solubulity and Delivery Systems (3 papers), Biochemical and Molecular Research (2 papers) and Pharmaceutical studies and practices (2 papers). Robert A. Lipper collaborates with scholars based in United States, Germany and Singapore. Robert A. Lipper's co-authors include W.I. Higuchi, Vinod P. Shah, E Gupta, Ankie M. Harmsze, Jennifer Dressman, D.M. Barends, Kimberley A. Lentz, William I. Higuchi, James E. Polli and Yunhui Wu and has published in prestigious journals such as Molecular Pharmacology, Journal of Pharmaceutical Sciences and European Journal of Pharmaceutical Sciences.

In The Last Decade

Robert A. Lipper

8 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Lipper United States	5	143	74	62	58	54	8	323
Tapon Roy United States	5	191 1.3×	91 1.2×	40 0.6×	17 0.3×	30 0.6×	10	350
Jonas H. Fagerberg Sweden	9	299 2.1×	78 1.1×	132 2.1×	41 0.7×	200 3.7×	11	478
Shin‐ichi Fujiwara Japan	9	57 0.4×	237 3.2×	78 1.3×	75 1.3×	42 0.8×	18	402
Kimberly Raines United States	9	147 1.0×	69 0.9×	32 0.5×	24 0.4×	69 1.3×	13	256
Thomas J. Mikkelson United States	12	160 1.1×	122 1.6×	63 1.0×	19 0.3×	8 0.1×	15	511
Jef Stappaerts Belgium	12	301 2.1×	111 1.5×	98 1.6×	11 0.2×	96 1.8×	22	492
Earvin Liang United States	11	47 0.3×	148 2.0×	35 0.6×	24 0.4×	22 0.4×	20	353
Kim Knuth United States	10	153 1.1×	80 1.1×	89 1.4×	36 0.6×	5 0.1×	11	380
Sandra Suarez‐Sharp United States	11	337 2.4×	139 1.9×	71 1.1×	47 0.8×	167 3.1×	22	505
Ian Knemeyer United States	8	115 0.8×	163 2.2×	188 3.0×	17 0.3×	14 0.3×	9	500

Countries citing papers authored by Robert A. Lipper

Since Specialization

Citations

This map shows the geographic impact of Robert A. Lipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Lipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Lipper more than expected).

Fields of papers citing papers by Robert A. Lipper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Lipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Lipper. The network helps show where Robert A. Lipper may publish in the future.

Co-authorship network of co-authors of Robert A. Lipper

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Lipper. A scholar is included among the top collaborators of Robert A. Lipper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Lipper. Robert A. Lipper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Danese, Silvio, Britta Siegmund, Bram Verstockt, et al.. (2025). P0627 Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Oral Resolvin E1-based Therapy in Inflammatory Bowel Disease (IBD): Translating Resolvin E1 Activation of BLT1 in Experimental Models to Healthy Volunteers. Journal of Crohn s and Colitis. 19(Supplement_1). i1237–i1237. 1 indexed citations

Polli, James E., Bertil Abrahamsson, Lawrence X. Yu, et al.. (2008). Summary Workshop Report: Bioequivalence, Biopharmaceutics Classification System, and Beyond. The AAPS Journal. 10(2). 373–379. 47 indexed citations

Gupta, E, D.M. Barends, Kimberley A. Lentz, et al.. (2006). Review of global regulations concerning biowaivers for immediate release solid oral dosage forms. European Journal of Pharmaceutical Sciences. 29(3-4). 315–324. 51 indexed citations

Lipper, Robert A., et al.. (2000). Role of the Development Scientist in Compound Lead Selection and Optimization. Journal of Pharmaceutical Sciences. 89(2). 145–154. 173 indexed citations

Chen, Chih‐Ming, et al.. (1986). Degradation Kinetics and Mechanism of N6-[(Dimethylamino)methylene]mitomycin C in Aqueous Solutions. Journal of Pharmaceutical Sciences. 75(2). 208–210. 3 indexed citations

Lipper, Robert A., et al.. (1978). Inhibition of Drug Metabolism by a Prodrug: 9-β-D-Arabinofuranosyladenine 5'-Valerate as an Inhibitor of Adenosine Deaminase. Molecular Pharmacology. 14(2). 366–369. 2 indexed citations

Lipper, Robert A., et al.. (1978). Inhibition of drug metabolism by a prodrug: 9-beta-D-arabinofuranosyladenine 5'-valerate as an inhibitor of adenosine deaminase.. PubMed. 14(2). 366–9. 9 indexed citations

Lipper, Robert A. & W.I. Higuchi. (1977). Analysis of Theoretical Behavior of a Proposed Zero-Order Drug Delivery System. Journal of Pharmaceutical Sciences. 66(2). 163–164. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact